193 related articles for article (PubMed ID: 9031106)
1. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
Jotterand M; Parlier V
Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
[TBL] [Abstract][Full Text] [Related]
2. [Chromosome 17 abnormalities in patients with primary myelodysplastic syndrome: incidence and biologic significance].
Marisavljević D; Rolović Z; Panitić M; Novak A; Djordjević V; Lazarević V; Bosković D; Colović M
Srp Arh Celok Lek; 2004; 132(1-2):10-3. PubMed ID: 15227958
[TBL] [Abstract][Full Text] [Related]
3. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes.
Schmetzer HM; Poleck B; Duell T; Gerhartz HH; Mittermüller J
Ann Hematol; 2000 Jan; 79(1):20-9. PubMed ID: 10663617
[TBL] [Abstract][Full Text] [Related]
9. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
10. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
[TBL] [Abstract][Full Text] [Related]
14. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal abnormalities in primary myelodysplastic syndrome.
Rashid A; Khurshid M; Shaikh U; Adil S
J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic findings in primary and secondary MDS.
Heim S
Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
[TBL] [Abstract][Full Text] [Related]
20. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
